NovaScan, a clinical stage oncology company pioneering a new low cost point of care platform for cancer detection and treatment, announced that it has completed a $8 Million Series B financing, led by Builders VC. As a part of this transaction, Amit Mehta, MD, a partner at Builders, will join the Board of Directors of NovaScan.
”We are excited about what this financing enables.” remarked NovaScan CEO Craig Davis. “We plan to advance several key offerings towards commercialization and exit. We are thrilled to partner with Builders VC, a leading venture capital firm experienced in capitalizing on disruptive technologies. We believe their counsel and contacts will help us achieve better returns for our shareholders.”